Results 11 to 20 of about 2,454,151 (187)

Neuromyelitis optica spectrum disorder

Advances in Clinical Neuroscience & Rehabilitation, 2017
Over the past 13 years neuromyelitis optica spectrum disorder (NMOSD) has emerged as a discrete form of demyelinating disease of the central nervous system in which antibodies against a water channel found in high concentration on astrocytes are ...
Simon Broadley, Elham Khalili, Saman Heshmat, Laura Clarke   +3 more
doaj   +2 more sources

Neuromyelitis optica spectrum disorder – case report

Studia Medyczne, 2016
The study presents the case of a 45-year-old woman with a rare case of Devic’s disease (neuromyelitis optica – NMO) admitted to the Department of Rehabilitation in Kielce.
Grażyna Ściegienna-Zdeb, Marta Mierzwa-Molenda   +1 more
doaj   +2 more sources

Higher frequency of brain abnormalities in neuromyelitis optica spectrum disorder patients without primary Sjögren′s syndrome

Neural Regeneration Research, 2016
Neuromyelitis optica spectrum disorder often co-exists with primary Sjögren′s syndrome. We compared the clinical features of 16 neuromyelitis optica spectrum disorder patients with (n = 6) or without primary Sjögren′s syndrome (n = 10).
Li-na Gu, Min Zhang, Hui Zhu, Jing-yao Liu   +3 more
doaj   +2 more sources

Relapse of Neuromyelitis Optica Spectrum Disorder Associated with Intravenous Lidocaine [PDF]

Case Reports in Medicine, 2011
Lidocaine unmasks silent symptoms and eases neuropathic pain in multiple sclerosis patients; however, the effects of lidocaine in neuromyelitis optica have never been reported.
Akiyuki Uzawa, Masahiro Mori, Saeko Masuda, Kazuhiko Aoe, Satoshi Kuwabara   +4 more
doaj   +2 more sources

Frequency of cognitive impairment in patients with neuromyelitis optica spectrum disorder in Mexico [PDF]

Multiple Sclerosis Journal - Experimental, Translational and Clinical
Background Between 29% and 67% of neuromyelitis optica spectrum disorder patients have cognitive alterations. Objective To assess the frequency of cognitive impairment in patients with neuromyelitis optica spectrum disorder in Mexico using the Brief ...
Edgar R Valdivia-Tangarife, Fernando Cortés-Enríquez, Alejandra Morlett-Paredes, Teresita Villaseñor-Cabrera, Jorge I Gámez-Nava, Mario A Mireles-Ramírez, Laura González-López, Miguel Á Macías-Islas   +7 more
doaj   +2 more sources

Central Sleep Apnea Syndrome Can Complicate Neuromyelitis Optica Spectrum Disorder: A Case Report

Frontiers in Pediatrics, 2020
Neuromyelitis optica spectrum disorder is a rare, relapsing autoimmune disease of the central nervous system. Various initial presentations can delay diagnosis and treatment.
Céline Morelli, Alec Aeby, Sonia Scaillet, Sonia Scaillet, Grammatina Boitsios, Daphné Vens, Daphné Vens, Cynthia Prigogine, Cynthia Prigogine, Dominique Biarent, Alfredo Vicinanza   +10 more
doaj   +2 more sources

Immunoadsorption in patients with neuromyelitis optica spectrum disorder [PDF]

Therapeutic Advances in Neurological Disorders, 2016
Introduction: Neuromyelitis optica spectrum disorder (NMOSD) is a neuroinflammatory disorder of the central nervous system, distinct from multiple sclerosis by affecting predominantly the optic nerve and the spinal cord, and mediated by antibodies ...
Simon Faissner, Johanna Nikolayczik, Andrew Chan, Ralf Gold, Min-Suk Yoon, Aiden Haghikia   +5 more
doaj   +2 more sources

Update on neuromyelitis optica: natural history and management

Eye and Brain, 2012
Panitha Jindahra1,2, Gordon T Plant1,21The National Hospital for Neurology and Neurosurgery, Queen Square, London, UK; 2St Thomas' Hospital, Westminster Bridge Road, London, UKAbstract: Neuromyelitis optica or Devic disease is an inflammatory ...
Jindahra P, Plant GT
doaj   +1 more source

Efficacy of dalfampridine in neuromyelitis optica spectrum disorder: A pilot study

Multiple Sclerosis Journal - Experimental, Translational and Clinical
Objective To assess the efficacy of dalfampridine in patients with neuromyelitis optica spectrum disorder. Methods We included 15 consecutive patients, who were started on a treatment of dalfampridine 10 mg twice daily for 2 weeks.
Jérôme de Seze, Christine Clerc, Matthieu Béreau, Bertrand Bourre, Hélène Zephir, Nicolas Collongues, Laurent Kremer, Patrick Vermersch, Kevin Bigaut   +8 more
doaj   +2 more sources

Opsoclonus-Myoclonus-Ataxia Revealing Underlying Neuromyelitis Optica Spectrum Disorder. [PDF]

Mov Disord Clin Pract
Movement Disorders Clinical Practice, EarlyView.
Verde ASSL, de Paiva Santos Rolim F, Catunda AV, Filho JOFT, Pitombeira MS, Carvalho FMM, de Assis Pereira Matos PCA.   +6 more
europepmc   +2 more sources